Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations

This comparative effectiveness research study examines the effectiveness of full vaccination with Ad26.COV2.S vs BNT162b2 against COVID-19–related hospitalization.

Detalles Bibliográficos
Autores principales: Botton, Jérémie, Semenzato, Laura, Jabagi, Marie-Joëlle, Baricault, Bérangère, Weill, Alain, Dray-Spira, Rosemary, Zureik, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892225/
https://www.ncbi.nlm.nih.gov/pubmed/35234883
http://dx.doi.org/10.1001/jamanetworkopen.2022.0868
_version_ 1784662108280979456
author Botton, Jérémie
Semenzato, Laura
Jabagi, Marie-Joëlle
Baricault, Bérangère
Weill, Alain
Dray-Spira, Rosemary
Zureik, Mahmoud
author_facet Botton, Jérémie
Semenzato, Laura
Jabagi, Marie-Joëlle
Baricault, Bérangère
Weill, Alain
Dray-Spira, Rosemary
Zureik, Mahmoud
author_sort Botton, Jérémie
collection PubMed
description This comparative effectiveness research study examines the effectiveness of full vaccination with Ad26.COV2.S vs BNT162b2 against COVID-19–related hospitalization.
format Online
Article
Text
id pubmed-8892225
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-88922252022-03-04 Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations Botton, Jérémie Semenzato, Laura Jabagi, Marie-Joëlle Baricault, Bérangère Weill, Alain Dray-Spira, Rosemary Zureik, Mahmoud JAMA Netw Open Research Letter This comparative effectiveness research study examines the effectiveness of full vaccination with Ad26.COV2.S vs BNT162b2 against COVID-19–related hospitalization. American Medical Association 2022-03-02 /pmc/articles/PMC8892225/ /pubmed/35234883 http://dx.doi.org/10.1001/jamanetworkopen.2022.0868 Text en Copyright 2022 Botton J et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Botton, Jérémie
Semenzato, Laura
Jabagi, Marie-Joëlle
Baricault, Bérangère
Weill, Alain
Dray-Spira, Rosemary
Zureik, Mahmoud
Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations
title Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations
title_full Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations
title_fullStr Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations
title_full_unstemmed Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations
title_short Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations
title_sort effectiveness of ad26.cov2.s vaccine vs bnt162b2 vaccine for covid-19 hospitalizations
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892225/
https://www.ncbi.nlm.nih.gov/pubmed/35234883
http://dx.doi.org/10.1001/jamanetworkopen.2022.0868
work_keys_str_mv AT bottonjeremie effectivenessofad26cov2svaccinevsbnt162b2vaccineforcovid19hospitalizations
AT semenzatolaura effectivenessofad26cov2svaccinevsbnt162b2vaccineforcovid19hospitalizations
AT jabagimariejoelle effectivenessofad26cov2svaccinevsbnt162b2vaccineforcovid19hospitalizations
AT baricaultberangere effectivenessofad26cov2svaccinevsbnt162b2vaccineforcovid19hospitalizations
AT weillalain effectivenessofad26cov2svaccinevsbnt162b2vaccineforcovid19hospitalizations
AT drayspirarosemary effectivenessofad26cov2svaccinevsbnt162b2vaccineforcovid19hospitalizations
AT zureikmahmoud effectivenessofad26cov2svaccinevsbnt162b2vaccineforcovid19hospitalizations

Ejemplares similares